Donepezil in Alzheimer’s Disease: What to Expect after 3 Years of Treatment in a Routine Clinical Setting

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1969 • 16,855 citations

A new rating scale for Alzheimer's disease

1984 • 3,948 citations

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1978 • 2,036 citations

Cholinesterase inhibitors for Alzheimer's disease

2006 • 1,799 citations

A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

1994 • 953 citations

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial

2004 • 888 citations

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD

2001 • 723 citations

Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

2000 • 689 citations

Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change

1997 • 620 citations

Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric Symptoms and Functional Impairment in Alzheimer Disease

2003 • 516 citations

A POST-MORTEM STUDY OF THE CHOLINERGIC AND GABA SYSTEMS IN SENILE DEMENTIA

1982 • 449 citations

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration

1994 • 401 citations

Open-Label, Multicenter, Phase 3 Extension Study of the Safety and Efficacy of Donepezil in Patients With Alzheimer Disease

2001 • 359 citations

Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC)

1997 • 310 citations

Longitudinal evaluation of dementia of the Alzheimer type

1990 • 273 citations

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

2000 • 265 citations

Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups

1983 • 223 citations

The Clinician Interview‐ Based Impression (CIBI)

1994 • 213 citations

Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden

2003 • 207 citations

Use of Cholinesterase Inhibitors in Clinical Practice: Evidence-Based Recommendations

2003 • 202 citations

Tracking Cognitive Decline in Alzheimer's Disease Using the Mini-Mental State Examination: A Meta-Analysis

2000 • 187 citations

3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy

2006 • 171 citations

The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months

2004 • 163 citations

Metaanalysis of Randomized Trials of the Efficacy and Safety of Donepezil, Galantamine, and Rivastigmine for the Treatment of Alzheimer Disease

2004 • 159 citations

Modelling Mini Mental State Examination changes in Alzheimer's disease

2000 • 145 citations

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).

1995 • 104 citations

Long‐term efficacy and safety of galantamine in patients with mild‐to‐moderate Alzheimer's disease: multicenter trial

2004 • 95 citations

Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years

2005 • 90 citations

The Relationship Between Donepezil and Behavioral Disturbances in Patients With Alzheimer's Disease

2000 • 72 citations

Long-Term Cholinesterase Inhibitor Treatment of Alzheimer???s Disease

2004 • 68 citations

The cholinergic deficit in Alzheimer's disease.

1998 • 63 citations

Oral Tetrahydroaminoacridine Treatment of Alzheimer's Disease Evaluated Clinically and by Regional Cerebral Blood Flow and EEG

1993 • 59 citations

Disease Stage in Alzheimer Disease and Treatment Effects of Rivastigmine

2004 • 54 citations

Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease

2005 • 50 citations

Rates of change of common measures of impairment in senile dementia of the Alzheimer's type.

1988 • 49 citations

Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

1997 • 46 citations

A videotaped CIBIC for dementia patients

2002 • 46 citations

Five-Year Outcome of Cholinergic Treatment of Alzheimer’s Disease: Early Response Predicts Prolonged Time until Nursing Home Placement, but Does Not Alter Life Expectancy

2004 • 45 citations

Rivastigmine in Alzheimer Disease

2004 • 43 citations

Differential Efficacy of Treatment with Acetylcholinesterase Inhibitors in Patients with Mild and Moderate Alzheimer’s Disease over a 6-Month Period

2005 • 40 citations

Donepezil in the treatment of patients with Alzheimer’s disease

2001 • 8 citations

Deleted Work

1955 • 0 citations